skip to main content
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: BACON - Mir@bel - GLOBAL_LIBRESACCES remover Base de dados/Biblioteca: Elsevier ScienceDirect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Activation of T Cell Calcium Influx by the Second Messenger ADP-ribose
Material Type:
Artigo
Adicionar ao Meu Espaço

Activation of T Cell Calcium Influx by the Second Messenger ADP-ribose

Gasser, Andreas ; Glassmeier, Günter ; Fliegert, Ralf ; Langhorst, Matthias F. ; Meinke, Stephan ; Hein, Dörte ; Krüger, Sylvia ; Weber, Karin ; Heiner, Inka ; Oppenheimer, Norman ; Schwarz, Jürgen R. ; Guse, Andreas H.

The Journal of biological chemistry, 2006-02, Vol.281 (5), p.2489-2496 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

2
2017 Black Box Amnog Rebates: What Is Driving The Rebates?
Material Type:
Artigo
Adicionar ao Meu Espaço

2017 Black Box Amnog Rebates: What Is Driving The Rebates?

Freiberg, M ; Schwarz, R

Value in health, 2017-10, Vol.20 (9), p.A676 [Periódico revisado por pares]

Lawrenceville: Elsevier Science Ltd

Texto completo disponível

3
PHP139 - 2017 Black Box Amnog Rebates: What Is Driving The Rebates?
Material Type:
Artigo
Adicionar ao Meu Espaço

PHP139 - 2017 Black Box Amnog Rebates: What Is Driving The Rebates?

Freiberg, M ; Schwarz, R

Value in health, 2017-10, Vol.20 (9), p.A676-A676 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

4
PSY145 - How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?
Material Type:
Artigo
Adicionar ao Meu Espaço

PSY145 - How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?

Schwarz, R ; Freiberg, M

Value in health, 2016-11, Vol.19 (7), p.A600-A600 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

5
How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?
Material Type:
Artigo
Adicionar ao Meu Espaço

How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?

Schwarz, R ; Freiberg, M

Value in health, 2016-11, Vol.19 (7), p.A600-A600 [Periódico revisado por pares]

Texto completo disponível

6
Glycosylphosphatidylinositols synthesized by asexual erythrocytic stages of the malarial parasite, Plasmodium falciparum. Candidates for plasmodial glycosylphosphatidylinositol membrane anchor precursors and pathogenicity factors
Material Type:
Artigo
Adicionar ao Meu Espaço

Glycosylphosphatidylinositols synthesized by asexual erythrocytic stages of the malarial parasite, Plasmodium falciparum. Candidates for plasmodial glycosylphosphatidylinositol membrane anchor precursors and pathogenicity factors

Gerold, P ; Dieckmann-Schuppert, A ; Schwarz, R T

The Journal of biological chemistry, 1994-01, Vol.269 (4), p.2597-2606 [Periódico revisado por pares]

Bethesda, MD: American Society for Biochemistry and Molecular Biology

Texto completo disponível

7
PMD39 HOSPITAL REIMBURSEMENT PATHWAYS FOR NEW EXAMINATION AND TREATMENT METHODS IN GERMANY
Material Type:
Artigo
Adicionar ao Meu Espaço

PMD39 HOSPITAL REIMBURSEMENT PATHWAYS FOR NEW EXAMINATION AND TREATMENT METHODS IN GERMANY

Worf, K. ; Schuh, I. ; Scheler, E. ; Schwarz, R. ; Bonduelle, D.

Value in health, 2019-11, Vol.22, p.S676-S676 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

8
PHP16 - Biosimilars: Market Access and Market Penetration – A Comparison of France and Germany
Material Type:
Artigo
Adicionar ao Meu Espaço

PHP16 - Biosimilars: Market Access and Market Penetration – A Comparison of France and Germany

Freiberg, M ; Schwarz, R ; Khoury, C

Value in health, 2016-11, Vol.19 (7), p.A442-A442 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

9
Biosimilars: Market Access and Market Penetration – A Comparison of France and Germany
Material Type:
Artigo
Adicionar ao Meu Espaço

Biosimilars: Market Access and Market Penetration – A Comparison of France and Germany

Freiberg, M ; Schwarz, R ; Khoury, C

Value in health, 2016-11, Vol.19 (7), p.A442-A442 [Periódico revisado por pares]

Texto completo disponível

10
How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?
Material Type:
Artigo
Adicionar ao Meu Espaço

How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?

Freiberg, M ; Schwarz, R ; Fath, F

Value in health, 2015-11, Vol.18 (7), p.A550-A550 [Periódico revisado por pares]

United States

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
  1. Antes de1988  (14)
  2. 1988Até1996  (23)
  3. 1997Até2004  (50)
  4. 2005Até2014  (31)
  5. Após 2014  (49)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.